Skip to Content

What is the Siliq REMS Program?

Medically reviewed by Last updated on June 25, 2020.

Official Answer


Due to possible risks associated with Siliq, this medicine can only be accessed through a restricted program called the Siliq Risk Evaluation and Mitigation Strategy (REMS) program. Suicidal ideation and behavior, including completed suicides, occurred in patients treated with Siliq during clinical trials, but a definite link with the drug has not been determined.,

Components of the Siliq REMS program include:

  • Prescriber Certification and Patient Counseling
  • A Patient-Prescriber Agreement Form to seek medical care if suicidal thoughts, depression, or mood changes occur
  • A Medication Guide to inform patients of the risk of using Siliq
  • Pharmacies must be certified only dispense to patients who are authorized to receive Siliq.

Siliq (brodalumab) injection is FDA-approved to treat adults with moderate-to-severe plaque psoriasis.

Related Medical Questions

Drug Information

Related Support Groups